Assistant Professor, Medicine, USC School of Medicine
Oncology
Dr. Amir Goldkorn, MD
|
|
Give Review
Dr. Amir Goldkorn works in the field of Oncology. He researched medicine at David Geffen School of Medicine at UCLA. David Geffen School of Medicine at UCLA is one of the top medical schools in the US. David Geffen School of Medicine at UCLA is ranked 13 in research and 7 in primary care medicine Amir Goldkorn is a published physician. He has 19 papers published. The most current publication "Cortical variability and asymmetry in normal aging and Alzheimer's disease."
Publications
- New prostate cancer drugs: extending and improving life.
- Circulating tumor cells in prostate cancer: a better predictor of survival than prostate specific antigen?
- Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase 3 metastatic castration resistant prostate cancer trial.
- Circulating Tumor Cell Counts Are Prognostic of Overall Survival in SWOG S0421: A Phase III Trial of Docetaxel With or Without Atrasentan for Metastatic Castration-Res...
- Serum Biomarkers of Bone Metabolism in Castration-Resistant Prostate Cancer Patients With Skeletal Metastases: Results From SWOG 0421.
- Cancer cells acquire a drug resistant, highly tumorigenic, cancer stem-like phenotype through modulation of the PI3K/Akt/β-catenin/CBP pathway.
- Efficacy of oxaliplatin plus pemetrexed in chemotherapy pretreated metastatic castration-resistant prostate cancer.
- Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial.
- Perillyl alcohol for the treatment of temozolomide-resistant gliomas.
- Cortical variability and asymmetry in normal aging and Alzheimer's disease.
- Sulcal variability in the Alzheimer's brain: correlations with cognition.
- Telomerase targeted therapy in cancer and cancer stem cells.
- Targeted therapy in renal cancer.
- Cancer cells cyclically lose and regain drug-resistant highly tumorigenic features characteristic of a cancer stem-like phenotype.
- Prostate tumor cells with cancer progenitor properties have high telomerase activity and are rapidly killed by telomerase interference.
- A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter.
- Reprogramming murine telomerase rapidly inhibits the growth of mouse cancer cells in vitro and in vivo.
- Assembly of mutant-template telomerase RNA into catalytically active telomerase ribonucleoprotein that can act on telomeres is required for apoptosis and cell cycle ar...
Schools
University of California At Los Angeles
UCLA School MedUCLA Med Center
University Ca San Francisco
Conditions Treated
- Soft Tissue Sarcoma
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
UCSF -
UCLA Medical Center -
David Geffen School of Medicine at UCLA
Hospital
-
Keck Hospital of USC
Helpful Reviews
Similar Doctors
|
|
Dr. Gilbert J. Hum, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Dennis R. Holmes, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Matthew Rettig, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christy A. Russell, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. David S. Finley, MD |
|
|
Dr. Cary H. Gota, MD |
|
|
Dr. Eric C. McGary, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Allen B. Bredt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fariborz Mortazavi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James S. Hu, MD
This Doctor is OpenDoctor Recommended.
|